Stability of High‐Quality Warfarin Anticoagulation in a Community‐Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

Stability of High‐Quality Warfarin Anticoagulation in a Community‐Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

BackgroundWarfarin reduces ischemic stroke risk in atrial fibrillation (AF) but increases bleeding risk. Novel anticoagulants challenge warfarin as stroke‐preventive therapy for AF. They are available at fixed doses but are more costly. Warfarin anticoagulation at a time in therapeutic range (TTR) ≥...

Full description

Bibliographic Details
Main Authors: Liane O. Dallalzadeh, Alan S. Go, Yuchiao Chang, Leila H. Borowsky, Margaret C. Fang, Daniel E. Singer
Format: Article
Language:English
Published: Wiley 2016-07-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
anticoagulants
arrhythmia
embolism
prevention
risk factors
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.116.003482

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.116.003482

Similar Items